WASHINGTON, DC—Coronary CT angiography (CCTA) seems to have the edge over functional testing for the assessment of suspected CAD in patients with newly diagnosed type 2 diabetes, real-world data show.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback